MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 171 filers reported holding MANNKIND CORP in Q2 2021. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,170,000 | +0.4% | 9,000,000 | -1.1% | 0.58% | +15.5% |
| Q2 2023 | $37,037,000 | -0.7% | 9,100,000 | 0.0% | 0.50% | -9.2% |
| Q1 2023 | $37,310,000 | -22.2% | 9,100,000 | 0.0% | 0.55% | -22.9% |
| Q4 2022 | $47,957,000 | +70.6% | 9,100,000 | 0.0% | 0.72% | +38.2% |
| Q3 2022 | $28,119,000 | -18.9% | 9,100,000 | 0.0% | 0.52% | -24.2% |
| Q2 2022 | $34,671,000 | +7.1% | 9,100,000 | +3.4% | 0.68% | +15.9% |
| Q1 2022 | $32,384,000 | -15.8% | 8,800,000 | 0.0% | 0.59% | -9.6% |
| Q4 2021 | $38,456,000 | +0.5% | 8,800,000 | 0.0% | 0.65% | +8.8% |
| Q3 2021 | $38,280,000 | -18.6% | 8,800,000 | +2.0% | 0.60% | -26.5% |
| Q2 2021 | $47,034,000 | +60.0% | 8,630,000 | +15.1% | 0.82% | +61.0% |
| Q1 2021 | $29,400,000 | +168.4% | 7,500,000 | +114.3% | 0.51% | +168.8% |
| Q4 2020 | $10,955,000 | – | 3,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 180 WEALTH ADVISORS, LLC | 1,482,638 | $6,078,816 | 1.41% |
| 1492 Capital Management LLC | 536,725 | $2,200,573 | 1.36% |
| Parkman Healthcare Partners LLC | 1,474,098 | $6,043,802 | 1.31% |
| EMERALD ADVISERS, LLC | 3,635,209 | $14,904,357 | 0.72% |
| Avoro Capital Advisors LLC | 9,100,000 | $37,310,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,879,671 | $7,706,651 | 0.46% |
| SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,849,340 | 0.27% |
| Bruce & Co., Inc. | 195,073 | $799,799 | 0.22% |
| SWAN Capital LLC | 28,850 | $118,285 | 0.11% |
| Woodline Partners LP | 1,834,280 | $7,520,548 | 0.10% |